Svas Biosana SpAMIL:SVS 80 OCF Margin % is 15.96% as of Dec. 2025, which is 249% above its 10-year median of 4.57. GuruFocus rates MIL:SVS with a GF Score™ of 80/100 and a GF Value™ of €9.63 (Fairly Valued). The stock has 3 warning signs investors should review. Among 818 Medical Devices & Instruments companies, Svas Biosana SpA ranks worse than 53.3% on this metric.
The historical rank and industry rank for Svas Biosana SpA's OCF Margin % or its related term are showing as below:
MIL:SVS'
s OCF Margin % Range Over the Past 10 Years
Min: 3.13 Med: 4.57 Max: 14.99
Current: 4.54
During the past 8 years, the highest OCF Margin % of Svas Biosana SpA was 14.99%. The lowest was 3.13%. And the median was 4.57%.
MIL:SVS's OCF Margin % is ranked worse than 53.3% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 5.785
vs MIL:SVS: 4.54
Svas Biosana SpA OCF Margin % Related Terms
Svas Biosana SpA OCF Margin % Historical Data
* Premium members only.
The historical data trend for Svas Biosana SpA's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Svas Biosana SpA's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Svas Biosana SpA OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Svas Biosana SpA's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Svas Biosana SpA's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Svas Biosana SpA (MIL:SVS) has a OCF Margin % of 15.96% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Svas Biosana SpA and its competitors. This is 249% above median its historical median of 4.57. Over the past decade, Svas Biosana SpA's OCF Margin % has ranged from 3.13 to 14.99. According to the industry distribution chart, Svas Biosana SpA ranks #436 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Svas Biosana SpA's OCF Margin % too high?
Svas Biosana SpA's current OCF Margin % of 15.96% is 249% above median its 10-year median of 4.57. Over the past 10 years, this metric has ranged from a low of 3.13 to a high of 14.99. The Medical Devices & Instruments industry median OCF Margin % is 5.79. Svas Biosana SpA's value of 15.96% is 175.9% above this industry median. Based on the distribution chart, Svas Biosana SpA ranks #436 out of 818 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Svas Biosana SpA has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Svas Biosana SpA's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Svas Biosana SpA ranks #436 out of 818 companies for OCF Margin %. This places Svas Biosana SpA in the lower half of its industry. The industry median OCF Margin % is 5.79. Svas Biosana SpA's value of 15.96% is 175.9% above this benchmark. Historically, Svas Biosana SpA's own OCF Margin % has ranged from 3.13 to 14.99 over the past decade. While the company's 10-year median is 4.57 vs. the industry median of 5.79, Svas Biosana SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.79, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Svas Biosana SpA's current OCF Margin % of 15.96% is 175.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Svas Biosana SpA and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Svas Biosana SpA's current OCF Margin % is 15.96%, which is 249% above median its own 10-year median of 4.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Svas Biosana SpA stock overvalued right now?
Based on GuruFocus' analysis, Svas Biosana SpA (MIL:SVS) is currently considered Fairly Valued. The stock's GF Value™ is €9.63, compared to a current price of €9.24 — trading 4% below its estimated fair value. The current OCF Margin % is 15.96%, which is 249% above median its 10-year median of 4.57 and 175.9% above the Medical Devices & Instruments industry median of 5.79. Svas Biosana SpA's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Svas Biosana SpA (MIL:SVS), the current OCF Margin % is 15.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Svas Biosana SpA (MIL:SVS) Overvalued in 2026?
Based on GuruFocus' analysis, Svas Biosana SpA stock appears to be undervalued.
The current stock price of €9.24 is trading 4% below its estimated GF Value™ of €9.63.
GuruFocus considers Svas Biosana SpA to be Fairly Valued.
Key valuation signals for MIL:SVS:
OCF Margin %: 15.96% (249% above median its 10-year median of 4.57)
GF Value™: €9.63 vs. price of €9.24 (4% below fair value)
Industry Position: 175.9% above the Medical Devices & Instruments median (#436 of 818)
No single metric tells the full story. See the MIL:SVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SVS has been successfully added to your 
